Day

September 15, 2022
The FDA has approved a new neuromodulator named Daxxify which is produced by the company Revance.  Neuromodulators are those medications containing Botulinum Toxin (such as Botox, Dysport, Xeomin, and Jeuveau), which are typically used as a cosmetic procedure to reduce fine lines and wrinkles. What makes Daxxify different from the other neuromodulators is its longevity average...
Read More

Subscribe to Dr. Messenger’s Newsletter

Sign up for a weekly email newsletter from Dr. Messenger containing his latest posts.

Categories